Forward Look

Cellular immunotherapies can offer periods when people do not require treatment.

by Christina Bennett

Forward Look

Cancer survivors diagnosed early in life may have unanswered questions about their sexual health.

by Lindsey Konkel

Get Involved

Students Lara Jabbour and Nazanin Nayeri work to cheer up hospital staff and patients.

by Bradley Jones

Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.

by Laurie Adami

Studies indicate that many people with cancer have an antibody response to the vaccines, but this response may be reduced or absent in certain patients.

by Anna Goshua

Testing for hereditary mutations is increasingly recommended for people with cancer, but recommendations do not always translate into access to testing and appropriate counseling.

by Kate Yandell

Advances in screening and treatment mean there are more cancer survivors than ever, but survivors who struggle to work can face difficulty getting disability payments.

by Jen Tota McGivney

Testing children with cancer for hereditary mutations could impact their treatment and provide information relevant to other family members.

by Marcus A. Banks

Researchers are investigating who is at greatest risk for radiation-induced cancers.

by Kate Yandell

For people with melanoma who receive immune checkpoint inhibitors after surgery, side effects can remain even after treatment has been completed. These chronic side effects are most often mild.

by Anna Goshua